Nucleic Acid Therapeutics Market Scope And Analysis

  • Report Code : TIPRE00027648
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Nucleic Acid Therapeutics Market Outlook and Scope 2031

Buy Now

Nucleic Acid Therapeutics Market Report Nucleic Acid Therapeutics Market Size and Share Nucleic Acid Therapeutics Market Scope and Analysis

Nucleic Acid Therapeutics Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 12.7%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Type
  • Antagomir and RNA sponge
  • Antisense oligonucleotide therapy
  • Locked nucleic acid
  • Peptide nucleic acid oligo
  • RNAi therapy
  • Triplex-forming oligonucleotide
By Application
  • Genetic Disorders
  • Auto Immune Disorders
By End User
  • Research Institutes
  • Hospitals and Clinics
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Alnylam Pharmaceuticals Inc
  • Silence Therapeutics plc
  • Arbutus Biopharma Corporation
  • Genzyme Sanofi
  • Ionis Pharmaceuticals
  • Sarepta Therapeutics
  • Benitec Biopharma Inc
  • Arrowhead Pharmaceuticals
  • Biogen Inc